Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.346EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.93EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.512EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.349EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.265EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.401EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.362EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DN.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BW.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.312EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.13.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.220EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.142EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.523EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.599EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.128EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.451EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.313EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.402EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.609EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.344EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.556EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.245EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.403EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.636EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.126EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.47EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDQ.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.31.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DT.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DT.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCAEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.50EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.54EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GN.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.77 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.53 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used